Skip Navigation



Human Molecular Genetics Advance Access published online on November 13, 2007

Human Molecular Genetics, doi:10.1093/hmg/ddm333
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Supplementary Data
Right arrow All Versions of this Article:
17/4/587    most recent
ddm333v2
ddm333v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Lee Yean Wong, R.
Right arrow Articles by Finnell, R. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lee Yean Wong, R.
Right arrow Articles by Finnell, R. H.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2007. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Mouse Fkbp8 activity is required to inhibit cell death and establish dorso-ventral patterning in the posterior neural tube

Rebecca Lee Yean Wong1,*, Bogdan J. Wlodarczyk1, Kyung Soo Min1, Melissa L. Scott1, Susan Kartiko1, Wei Yu2, Michelle Y. Merriweather1, Peter Vogel4, Brian P. Zambrowicz4,5,6 and Richard H. Finnell1,3

1 Center for Environmental and Genetic Medicine, Institute of Biosciences and Technology, The Texas A&M University System Health Science Center, 2121 W. Holcombe Blvd, Houston, TX 77030, USA 2 Center for Molecular Development and Disease, Institute of Biosciences and Technology, The Texas A&M University System Health Science Center, 2121 W. Holcombe Blvd, Houston, TX 77030, USA 3 Texas Institute for Genomic Medicine, 2121 W. Holcombe Blvd, Houston, TX 77030, USA 4 Department of Pharmaceutical Biology, Lexicon Pharmaceuticals, Inc., 8800 Technology Forest Place, The Woodlands, TX 77381, USA 5 Department of Biotherapeutics, Lexicon Pharmaceuticals, Inc., 8800 Technology Forest Place, The Woodlands, TX 77381, USA 6 Department of Genetics, Lexicon Pharmaceuticals, Inc., 8800 Technology Forest Place, The Woodlands, TX 77381, USA

* To whom correspondence should be addressed. Rebecca Lee Yean Wong, Center for Environmental and Genetic Medicine, Institute of Biosciences and Technology, The Texas A&M University System Health Science Center, 2121 W. Holcombe Blvd, Houston, TX 77030, USA: Tel: +1 713 677 7667; Fax: +1 713 677 7784; Email: lwong{at}ibt.tamhsc.edu

Received October 4, 2007; Revised November 9, 2007; Accepted November 9, 2007

Neural tube defects (NTDs) are birth defects that can be disabling or lethal and are second only to cardiac defects in their prevalence among major human congenital malformations. Spina bifida is a NTD where the spinal cord is dysplastic, and the overlying spinal column is absent. At present, the molecular mechanisms underlying the spinal bifida development are largely unknown. In this study, we present a mouse Fkbp8 mutant that has an isolated and completely penetrant spina bifida, which is folate- and inositol-resistant. Fkbp8 mutants are not embryo-lethal, and they display striking features of human spina bifida including a dysplastic spinal cord, open neural canal, and disability. Loss of Fkbp8 leads to increased apoptosis in the posterior neural tube, demonstrating that in vivo FKBP8 inhibits cell death. Gene expression analysis of Fkbp8 mutants revealed a perturbation of expression of neural tube patterning genes, suggesting that endogenous FKBP8 activity establishes dorso-ventral patterning of the neural tube. These studies demonstrate that Fkbp8 is not important for embryo survival, but is essential for spinal neural tube patterning, and to block apoptosis, in the developing neural tube. The mutant Fkbp8 allele is a new experimental model which will be useful in dissecting the pathogenesis of spinal NTDs, and enhance our understanding of the etiology of human NTDs.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Hum Mol GenetHome page
R. Y. Walder, B. Yang, J. B. Stokes, P. A. Kirby, X. Cao, P. Shi, C. C. Searby, R. F. Husted, and V. C. Sheffield
Mice defective in Trpm6 show embryonic mortality and neural tube defects
Hum. Mol. Genet., November 15, 2009; 18(22): 4367 - 4375.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
V. L. Patterson, C. Damrau, A. Paudyal, B. Reeve, D. T. Grimes, M. E. Stewart, D. J. Williams, P. Siggers, A. Greenfield, and J. N. Murdoch
Mouse hitchhiker mutants have spina bifida, dorso-ventral patterning defects and polydactyly: identification of Tulp3 as a novel negative regulator of the Sonic hedgehog pathway
Hum. Mol. Genet., May 15, 2009; 18(10): 1719 - 1739.
[Abstract] [Full Text] [PDF]


Home page
Sci SignalHome page
I. F. Tsigelny, V. L. Kouznetsova, D. E. Sweeney, W. Wu, K. T. Bush, and S. K. Nigam
Analysis of Metagene Portraits Reveals Distinct Transitions During Kidney Organogenesis
Sci. Signal., December 9, 2008; 1(49): ra16 - ra16.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.